Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes [0.03%]
急性自身免疫性肝炎的临床表现及治疗效果研究
Abdulrahman A Aljumah,Hamad Al-Ashgar,Hind Fallatah et al.
Abdulrahman A Aljumah et al.
Introduction and aim: Autoimmune hepatitis (AIH) may present acutely, which can rapidly progress to fulminant type. This pattern has been described worldwide but is generally under-reported. We aim to describe the clinica...
Multicenter Study
Annals of hepatology. 2019 May-Jun;18(3):439-444. DOI:10.1016/j.aohep.2018.09.001 2019
Lindsay A Sobotka,Alice Hinton,Lanla F Conteh
Lindsay A Sobotka
Introduction and aim: Previous studies have identified treatment disparities in the treatment of hepatocellular carcinoma (HCC) based on insurance status and provider. Recent studies have shown more Americans have healthc...
Multicenter Study
Annals of hepatology. 2019 May-Jun;18(3):461-465. DOI:10.1016/j.aohep.2018.10.001 2019
Serum alanine transaminase levels predict type 2 diabetes risk among a middle-aged and elderly Chinese population [0.03%]
中年人和老年人血清谷丙转氨酶水平预测2型糖尿病风险
Yaru Li,Jing Wang,Xu Han et al.
Yaru Li et al.
Introduction and aim: It is indicated that high levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are associated with increased incident type 2 diabetes risk. However, whether serum ALT l...
No expression of HBV-human chimeric fusion transcript (HBx-LINE1) among Vietnamese patients with HBV-associated hepatocellular carcinoma [0.03%]
越南乙型肝炎相关肝细胞癌患者中不存在乙肝病毒-人类嵌合融合转录本(HBx-LINE1)的表达
Ngo Tat Trung,Le Trung Hai,Dao Phuong Giang et al.
Ngo Tat Trung et al.
Treatment response in primary biliary cholangitis: The role of autoimmune hepatitis features [0.03%]
原发性胆汁性胆管炎的治疗反应：自身免疫性肝炎特征的作用
Fernando Mané,Hélder Cardoso,Rodrigo Liberal et al.
Fernando Mané et al.
Introduction and aim: Primary biliary cholangitis is a rare disease with scarce epidemiological data in Southern Europe. The authors aimed to evaluate treatment response in a cohort of patients. ...
Observational Study
Annals of hepatology. 2019 May-Jun;18(3):488-493. DOI:10.1016/j.aohep.2018.11.006 2019
Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance [0.03%]
用于肝硬化代偿期患者肝癌结节检测的影像学方法比较研究
Massimo Iavarone,Mauro Viganò,Nicole Piazza et al.
Massimo Iavarone et al.
Introduction and aim: The American Association for the Study of the Liver (AASLD) recommends contrast computerized tomography (CT-scan) and magnetic resonance (MRI) to diagnose hepatocellular carcinoma (HCC) arising in ci...
Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155 [0.03%]
聚乙二醇干扰素α通过下调miR-155抑制肝癌细胞增殖
Ying Zhang,Xuefeng Li,Yong Zhang et al.
Ying Zhang et al.
Introduction and aims: Interferon-α (IFN) has shown potential benefits in patients with hepatocellular carcinoma (HCC), and these effects may be mediated by inhibiting cancer cell proliferation. However, the detailed mec...
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) [0.03%]
微生物群和非酒精性脂肪肝病/非酒精性肝炎(NAFLD/NASH)
Sebastião M B Duarte,Jose Tadeu Stefano,Claudia P Oliveira
Sebastião M B Duarte
Genetic predisposition, the intestinal microbiota (IM) and environmental factors, such as sedentary lifestyle and inadequate diet, should be considered as critical factors for the development of nonalcoholic fatty liver disease (NAFLD). Rec...
Accuracy of the BAR score in the prediction of survival after liver transplantation [0.03%]
BAR评分预测肝移植术后生存准确性分析
Jorge A Martínez,Sergio Pacheco,Jean P Bachler et al.
Jorge A Martínez et al.
Introduction and aim: The Balance of Risk (BAR) Score, a simple scoring system that combines six independent donor and recipient variables to predict outcome after liver transplantation (LT), was validated in a large U.S....
Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD) [0.03%]
瞬时弹性成像技术在非酒精性脂肪肝病（NAFLD）肝纤维化评估中表现最优
Cristiane V Tovo,Cristiane A Villela-Nogueira,Nathalie C Leite et al.
Cristiane V Tovo et al.
Introduction and aim: The gold-standard for fibrosis diagnosis in non-alcoholic fatty liver disease (NAFLD) is liver biopsy, despite its invasive approach, sampling limitations and variability among observers. The objecti...
Comparative Study
Annals of hepatology. 2019 May-Jun;18(3):445-449. DOI:10.1016/j.aohep.2018.09.003 2019